Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology.

Previous fund recipients are highlighted below:



Kim Midwood, The Kennedy Institute of Rheumatology

How does macrophage marker F4/80 control T cell tolerance during tumour progression? Finding new ways of taming inflammation to improve treatment options for people with cancer

David Church and Luciana Gneo, Henry Wellcome Building of Genomic Medicine

Vaccination for cancer prevention in Lynch Syndrome

Alistair Easton, Department of Oncology

Phenotyping Intra-epithelial Lymphocytes in Pre-Invasive Lesions